SHC1 and hepatocellular carcinoma: Numerous studies have associated SHC1 with various malignancies, where its overexpression significantly impacts the prognosis of patients with hepatocellular carcinoma (HCC), colorectal cancer, and esophageal squamous cell carcinoma [68–71].